Objective: Implement drug-drug and drug allergy interaction checks.

Measure: The EP has enabled this functionality for the entire EHR reporting period.

Exclusion: No exclusion.

YES/NO ATTESTATION:

Drug-drug and drug-allergy interaction checks are not tracked within the SOAPware Meaningful Use dashboards. This Meaningful Use measure requires that the eligible professional must attest YES to having enabled drug-drug and drug-allergy interaction checks for the length of the reporting period to meet this measure.

For more detailed information on this measure, please click on the reference link below. This CMS documentation includes information on exclusions, attestation requirements, a definition of terms, and important additional information.

Reference CMS: Drug Interaction Checks

Please contact our Training Department to obtain access to our Meaningful Use 2014 Resource Center that includes SOAPware's comprehensive step-by-step Meaningful Use 2014 Roadmaps and Clinical Quality Measures Roadmap, along with other helpful resources. To request access to our Meaningful Use 2014 Resource Center, please contact our Training Department by submitting at ticket: Training Ticket.